Author

B. B. Subudhi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Approach:experimental assay· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

P. mamidi· 3 shared A. Datey· 2 shared C. Mahish· 2 shared E. Laha· 2 shared S. Chatterjee· 2 shared S. Chattopadhyay· 2 shared S. De· 2 shared S. Ghosh· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

P. mamidi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The uniqueness of the Brazilian Yellow Fever Virus. Are the vaccines less effective against it?

P. mamidi, M. Gaur, B. Mishra, B. B. Subudhi, S. Rath, M. Mohanty

The study identifies two unique amino acid substitutions in Brazilian YFV strains that may reduce vaccine effectiveness by altering epitope binding.

bioRxiv · May 5, 2023 · PreprintMicrobiology

DNA damage response signaling is crucial for effective Chikungunya virus replication

S. Chatterjee, S. Kumar, P. Mamidi, A. Datey, S. Sengupta, C. Mahish, E. Laha, S. De, S. S. Keshry, T. K. Nayak, S. Ghosh, S. Singh, B. B. Subudhi, S. Chattopadhyay, S. Chattopadhyay

This study shows that Chikungunya virus (CHIKV) infection activates DNA damage response (DDR) pathways, increases DNA damage, and interacts with Chk2 and Chk1 to facilitate viral replication and cell cycle arrest.

bioRxiv · Apr 12, 2022Microbiology

Telmisartan restricts Chikungunya virus infection in vitro and in vivo through the AT1/ PPAR-γ/MAPKs pathways

S. De, P. Mamidi, S. Ghosh, S. S. Keshry, C. Mahish, S. S. Pani, E. Laha, A. Ray, A. Datey, S. Chatterjee, S. Singh, T. Mukherjee, S. Khamaru, S. Chattopadhyay, B. B. Subudhi, S. Chattopadhyay

This study shows Telmisartan reduces Chikungunya virus infection in vitro and in vivo by modulating host pathways including AT1/PPAR-γ/MAPKs.

bioRxiv · Jul 30, 2021Microbiology